Download the 2026 Economic Impact Report
Join Now
Join Now

Tribe Clinical Research Enrolls First Patient Globally in Pneumococcal Vaccine Trial

South Carolina — Tribe Clinical Research has become the first clinical research site globally to enroll a patient in a pneumococcal vaccine clinical trial focused on advancing prevention of pneumococcal disease, marking a key milestone in the study’s launch.

This achievement highlights Tribe Clinical Research’s commitment to accelerating clinical development and delivering high-quality research execution. Being first to enroll globally reflects the site’s operational excellence, strong patient engagement, and dedication to advancing innovative therapies.

“We are proud to play a leading role in this important study,” said pediatrician Justin Moll, MD. “Enrolling the first participant is a testament to the hard work of our team and the trust our patients and our partners place in us. Clinical research depends on individuals who are willing to participate, and we are grateful for their contribution to advancing medicine.”

Pneumococcal disease remains a significant public health concern, particularly for vulnerable populations including children and older adults. Clinical trials like this are essential to developing new strategies for prevention and improving health outcomes worldwide.

Tribe Clinical Research continues to partner with leading pharmaceutical organizations to bring cutting-edge adult and pediatric trials to its communities, with a focus on bringing hope to the future of medicine.

For more information about current and upcoming clinical trials, visit www.TribeClinicalResearch.com.

About Tribe Clinical Research

Tribe Clinical Research TM (TCR) is a South Carolina-based clinical research organization founded in 2020. Specializing in both adult and pediatric trials, TCR is committed to advancing medicine by combining clinical excellence with the highest research standards.

Driven by a mission to bring hope to patients who need it most, TCR partners with healthcare providers and industry sponsors to conduct trials across a wide range of therapeutic areas. With a deep commitment to community, patient outcomes, and innovation, Tribe Clinical Research is building a future where research and care go hand in hand.

Together we can make a difference, because advancing medicine takes more than a single person or practice—it takes a Tribe.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Join Today!

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.